[1]
A. T. C. de Almeida, E. B. de Sá, F. S. Vieira, and R. P. de S. e Benevides, “Impacts of a Brazilian pharmaceutical program on the health of chronic patients”, Rev. saúde pública, vol. 53, p. 20, Jan. 2019, doi: 10.11606/S1518-8787.2019053000733.